FEops HEARTguideTM vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by FEops
VS
by Verily

AI Verdict

Tool A, FEops HEARTguideTM, is a cloud-based AI platform for structural heart procedure planning, using predictive simulations from CT scans to optimize device sizing and positioning. In contrast, Tool B, Verily Study Watch, is a wearable device for continuous physiological monitoring in clinical research, collecting data like ECG and heart rate. While both utilize AI in cardiology and are cloud-based, their fundamental applications—pre-procedural planning versus remote physiological data collection for research—are distinct.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if your primary need is to optimize pre-procedural planning for complex structural heart interventions like TAVI or LAAO. This platform is ideal for clinicians seeking predictive simulations and AI-driven anatomical insights to precisely size and position devices, aiming to enhance procedural success and patient safety.

View FEops HEARTguideTM →

Choose Study Watch if…

Choose Verily Study Watch if your objective is to conduct long-term, continuous physiological monitoring for participants in clinical research studies. This wearable device is best suited for researchers requiring reliable, multi-sensor data collection (ECG, heart rate, movement) to analyze patterns and evaluate interventions in areas such as cardiology, neurology, or sleep medicine.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguideTM Study Watch
Deployment Cloud-based The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguideTM

FEops HEARTguide (Tool A) offers a rich, interactive cloud-based platform with 2D and 3D viewers, semi-automatic and manual measurement options, and a DICOM interface for seamless integration into clinical workflows, directly supporting physician decision-making. Verily Study Watch (Tool B) is a wearable designed for passive data collection from patients, with minimal on-device interaction, primarily serving clinical research rather than direct clinician interaction for procedure planning.

Clinical Value

FEops HEARTguideTM

FEops HEARTguide (Tool A) provides direct, actionable insights for structural heart procedure planning, including predictive simulations for device sizing and positioning, aiming to optimize patient outcomes and reduce complications. Verily Study Watch (Tool B) primarily collects continuous physiological data for clinical research, with its clinical value being more indirect through data analysis for digital biomarkers and understanding disease progression.

Pricing & Value

Tie

Both FEops HEARTguide (Tool A) and Verily Study Watch (Tool B) lack publicly disclosed pricing information, operating on models that require direct engagement with the companies for cost details. Without transparent pricing, a comparative assessment of their value for money is not possible.

Enterprise Readiness

FEops HEARTguideTM

Both tools are cloud-based, FDA cleared, and claim HIPAA compliance with BAAs. However, FEops HEARTguide (Tool A) explicitly highlights a DICOM interface for easy integration into existing clinical imaging workflows, demonstrating a clear path for enterprise adoption in hospitals. While Verily Study Watch (Tool B) is designed for large-scale clinical research, ongoing lawsuit allegations regarding HIPAA and BAAs, even if denied, introduce a potential concern for enterprise trust.

Innovation

FEops HEARTguideTM

FEops HEARTguide (Tool A) showcases higher innovation with its cutting-edge predictive simulation technology and digital twin platform, offering personalized, AI-driven insights for complex structural heart procedure planning. Verily Study Watch (Tool B), while valuable for robust data collection in research, utilizes wearable sensor technology that is a refinement of existing capabilities, rather than a fundamentally new AI application.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information offer detailed specifics on dedicated support channels or comprehensive documentation for either FEops HEARTguide (Tool A) or Verily Study Watch (Tool B). Both appear to operate on models where support and documentation are likely handled through direct engagement or partnership agreements, making a comparative judgment impossible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguideTM Study Watch
Name FEops HEARTguideTM Study Watch
Description FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Company FEops nv Verily Life Sciences
Primary Key Feature Predictive simulation technology for device-anatomy interaction Continuous physiological monitoring
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. In contrast, Verily Study Watch is a prescription-only, sensor-based wearable device primarily for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis.
FEops HEARTguideu2122 analyzes cardiac CT scans to provide AI-based anatomical measurements and predictive simulations of device-anatomy interaction for structural heart interventions. Verily Study Watch collects continuous physiological data from multiple sensors, including ECG, heart rate, electrodermal activity, and inertial movements, which is then processed using algorithms and machine learning in Verily's cloud platform for research analysis.
Both FEops HEARTguideu2122 and Verily Study Watch are FDA cleared, HIPAA compliant, and state they have a Business Associate Agreement (BAA). However, Verily is currently facing an ongoing lawsuit alleging breaches of BAAs and HIPAA violations, which the company denies.
FEops HEARTguideu2122 is primarily aimed at Cardiology, Cardiothoracic Surgery, and Radiology, focusing on structural heart interventions. Verily Study Watch serves Cardiology, Neurology, and Sleep Medicine, mainly for continuous physiological monitoring in clinical research.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.